Observational studyMedicine2025
Clinical efficacy of copper Gua Sha therapy based on the "Qi Channel Discharge" concept for cervical spondylosis with Qi stagnation and blood stasis in elderly patients.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study evaluates the clinical effectiveness of copper Gua Sha therapy guided by the Traditional Chinese Medicine concept of Qi Channel Discharge in elderly patients with cervical spondylosis characterized by qi stagnation and blood stasis and compares its efficacy with conventional copper Gua Sha therapy. A retrospective cohort study was conducted on 115 elderly patients diagnosed with qi stagnation and blood stasis-type cervical spondylosis at a local Traditional Chinese Medicine hospital between January 2022 and December 2023. Patients were divided into 2 groups: the exposure group (n = 56) received copper Gua Sha therapy based on the Qi Channel Discharge concept, while the control group (n = 59) received conventional copper Gua Sha therapy. Outcome measures included cervical spine function (assessed by Clinical Assessment Scale for Cervical Spondylosis and Neck Disability Index), pain intensity (McGill Pain Scale), overall clinical efficacy, syndrome scores of qi stagnation and blood stasis, and quality of life. Data were analyzed using SPSS 25.0 with significance set at P < .05. After 4 to 6 weeks of treatment, the exposure group demonstrated superior outcomes compared with the control group. Neck Disability Index scores decreased by 6.97 versus 4.50 (15.62 ± 1.92 vs 17.38 ± 2.71, P < .001), while Clinical Assessment Scale for Cervical Spondylosis total scores increased by 26.52 versus 17.68 (97.81 ± 9.56 vs 90.21 ± 10.62, P < .001). Pain intensity measured by the McGill scale was reduced more markedly in the exposure group (total score: 10.52 ± 1.82 vs 11.51 ± 2.99, P = .033; Visual Analogue Scale: 1.64 ± 0.72 vs 2.18 ± 0.61, P < .001). The overall clinical effective rate was 78.57% vs 69.49% (P = .002). Qi stagnation and blood stasis syndrome scores decreased by 6.22 versus 5.44 (P = .002), and quality of life improved significantly across physical (18.31 ± 1.86 vs 17.46 ± 2.61, P = .045), emotional (20.35 ± 2.31 vs 19.23 ± 1.08, P = .036), and functional domains (19.88 ± 0.89 vs 18.28 ± 2.15, P < .001). Copper Gua Sha therapy based on the Qi Channel Discharge concept is significantly more effective than conventional Gua Sha in improving cervical function, relieving pain, alleviating qi stagnation and blood stasis symptoms, and enhancing the overall quality of life in elderly patients with cervical spondylosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.